Status:
UNKNOWN
NIV and Glottis-diaphragm Synchrony
Lead Sponsor:
University Medical Center Nijmegen
Conditions:
Noninvasive Ventilation
NAVA Catheter
Eligibility:
All Genders
18+ years
Brief Summary
Noninvasive ventilation (NIV) can provide ventilatory support in selected patients with acute respiratory failure, for instance due to acute exacerbation of COPD and acute heart failure. Advantages of...
Eligibility Criteria
Inclusion
- Informed consent
- COPD
- Hypercapnic respiratory acidosis
- Clinical need of NIV ventilation on the intensive care
- NAVA catheter in situ
Exclusion
- Pre-existent muscle disease (congenital or acquired) or diseases / disorders known to be associated with myopathy including auto-immune diseases.
- Diabetes
- Upper airway/esophageal/mouth or face pathology (i.e. recent surgery, esophageal varices, diaphragmatic hernia)
- Recent (\< 1 month) nasal bleeding
- Allergic to xylocaïne
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01791335
Start Date
October 1 2012
Last Update
June 10 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Radboud
Nijmegen, Gelderland, Netherlands, 6500HB